Hutch News

Dr. Lawrence Fong, new Fred Hutch immunotherapy director, talks about how the field has transformed oncology

Dr. Lawrence Fong, new Fred Hutch immunotherapy director, talks about how the field has transformed oncology

In-house grant funding program will underpin efforts to advance therapies to clinical trials
Hutch NewsAugust 15, 2024
What's next for T-cell therapies: Q&A with Dr. Stanley Riddell

What's next for T-cell therapies: Q&A with Dr. Stanley Riddell

After approval of latest cellular therapy for non-Hodgkin lymphoma, the immunologist looks ahead
Hutch NewsFebruary 05, 2021
Fred Hutch President and Director Dr. Gary Gilliland announces plan to step down

Fred Hutch President and Director Dr. Gary Gilliland announces plan to step down

5 years of leadership reinforced Fred Hutch scientific excellence, collaborative research, partnerships and financial strength
Hutch NewsSeptember 17, 2019
Fred Hutch Statement Regarding the FDA Action on CTL019 Immunotherapy

Fred Hutch Statement Regarding the FDA Action on CTL019 Immunotherapy

Fred Hutch expert comments on FDA approval of new Novartis immunotherapy drug CTL019 — August 30, 2017
Hutch NewsAugust 30, 2017
Promising results in trial of engineered T cells in high-risk leukemia

Promising results in trial of engineered T cells in high-risk leukemia

High response rates to experimental immunotherapy in patients with treatment-resistant chronic lymphocytic leukemia
Hutch NewsJuly 17, 2017
Bezos family gives $35 million to Fred Hutch

Bezos family gives $35 million to Fred Hutch

‘What we are really giving is the gift of time’; funds will be invested in more world-class faculty to speed cures for cancer patients
Hutch NewsMarch 30, 2017
Bezos family gives $35 million to Fred Hutch

Bezos family gives $35 million to Fred Hutch

Transformative investment will be used to hire more world-class researchers to launch innovative approaches to curing cancer, said Fred Hutch President and Director Gilliland
News ReleasesMarch 30, 2017
Fred Hutch/SCCA transplant rates among best in U.S.

Fred Hutch/SCCA transplant rates among best in U.S.

Fred Hutch Bone Marrow Transplant Program recognized for outperforming expected one-year survival rates for allogeneic transplant patients
Hutch NewsDecember 22, 2016
‘A place where miracles happen’: Opening of Bezos Family Immunotherapy Clinic highlights patient-focused science

‘A place where miracles happen’: Opening of Bezos Family Immunotherapy Clinic highlights patient-focused science

Research symposium and ribbon cutting celebrates first-of-its-kind facility for experimental immunotherapies
Hutch NewsDecember 16, 2016
'A place where miracles happen': Opening of Bezos Family Immunotherapy Clinic highlights patient-focused science

'A place where miracles happen': Opening of Bezos Family Immunotherapy Clinic highlights patient-focused science

Research symposium and ribbon cutting celebrates first-of-its-kind facility for experimental immunotherapies
Hutch NewsDecember 13, 2016
Cost of survival: Coping with treatment complications beyond the cure

Cost of survival: Coping with treatment complications beyond the cure

Treatment complications can impact lives for years after cure but some cancers survivors are reluctant to reveal their pain
Hutch NewsNovember 04, 2016
Fred Hutch opens first-of-its kind Bezos Family Immunotherapy Clinic

Fred Hutch opens first-of-its kind Bezos Family Immunotherapy Clinic

Clinic will allow researchers to conduct twice as many immunotherapy trials, enable intensive patient monitoring to improve experimental therapies
Hutch NewsNovember 01, 2016